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The epidemiology of major depression in South Africa: 
Results from the South African Stress and Health study
Mark Tomlinson, Anna T Grimsrud, Dan J Stein, David R Williams, Landon Myer
Mental disorders are a major contributor to the burden of 
disease in all regions of the world, with about 14% of the 
global burden attributable to neuropsychiatric disorders.1 Even 
in sub-Saharan Africa, a region with the highest burden of 
communicable disease, neuropsychiatric disorders account for 
nearly 10% of the total burden of disease.2 Mental disorders are 
not only linked to many other health conditions, but are also 
among the most costly medical disorders in terms of projected 
health care expenditures needed to treat them.3 
Epidemiological studies and data on prevalence rates of 
major depressive disorders in Africa are limited. Of the studies 
that have been completed, many have used clinic attendance 
as a recruitment method,4 thus introducing a potential bias. 
In South Africa, small rural-based studies have found a 
prevalence rate of depressive symptomatology of 18%5 and a 
rate of depression of 27%.6 Other results include a prevalence 
of depression of 25.2%7 in an urban setting, while Cooper 
and colleagues8 found a 34.7% prevalence of postpartum 
depression in a peri-urban settlement in Cape Town. To 
date there have not been any nationally representative data 
on the prevalence of major depressive disorder in South 
Africa. In a resource-constrained setting such as South Africa, 
nationally representative data that include age of onset and 
role impairment comparisons are of crucial importance both in 
terms of highlighting the country’s burden of disease and to 
enable targeting of limited intervention funding. 
Method
Sample
The study formed part of the South African Stress and 
Health (SASH) study,9 which was part of the World Health 
Organization’s World Mental Health (WMH) 2000 initiative. 
The SASH study is a national probability survey of adult South 
Africans living in households and hostel quarters (the latter 
were included to maximise coverage of young working-age 
males). Individuals of all race and ethnic backgrounds were 
included in the study. The sample was selected using a three-
stage sample design. The first stage involved the stratified 
selection of primary sampling units based on the 2001 South 
African Census Enumeration Areas (EAs). The second stage 
involved the sampling of housing units within clusters selected 
in each EA. The third stage involved the random selection 
of one adult respondent in each sampled housing unit. Field 
interviewers made up to three attempts to contact respondents. 
A total sample of 5 089 households was selected for the SASH. 
Field interviews were obtained with 4 433 (87.1%) of the 
designated respondents. Based on quality control criteria, 4 351 
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Background. Mental disorders are a major contributor to 
the burden of disease in all regions of the world. There 
are limited data on the epidemiology of major depressive 
disorder in South Africa. 
Methods. A nationally representative household survey was 
conducted between 2002 and 2004 using the World Health 
Organization Composite International Diagnostic Interview 
(CIDI) to establish a diagnosis of depression. The dataset 
analysed included 4 351 adult South Africans of all racial 
groups.
Results. The prevalence of major depression was 9.7% for 
lifetime and 4.9% for the 12 months prior to the interview. 
The prevalence of depression was significantly higher among 
females than among males. The prevalence was also higher 
among those with a low level of education. Over 90% of all 
respondents with depression reported global role impairment.
Conclusion. In comparison with data from other countries, 
South Africa has lower rates of depression than the USA but 
higher rates than Nigeria. The findings are broadly consistent 
with previous findings in South Africa. These findings are the 
first step in documenting a level of need for care in a context 
of significant under-funding of mental health services and 
research in South Africa
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of the field interviews were retained for use in the analysis. 
There were no differences in response rates across racial 
groups.
Instruments
The diagnostic interview used in the SASH was the World 
Health Organization (WHO) Composite International 
Diagnostic Interview Version 3.010 (CIDI 3.0), a fully structured 
lay-administered interview that generates diagnoses according 
to the criteria of both the International Statistical Classification 
of Diseases and Related Health Problems, 10th revision (ICD-
10) and Diagnostic and Statistical Manual, 4th edition (DSM-
IV) diagnostic systems, and has been widely used in 
epidemiological studies throughout the world. The CIDI was 
translated from English into six other languages used in South 
Africa (virtually all South Africans speak at least one of these 
languages), and then back-translated. 
Respondents who were diagnosed with either 12-month 
or lifetime major depression were administered the Sheehan 
Disability Scale (SDS). The SDS assesses the extent to which 
depression interferes with functioning in the domains of 
work, household, relationship and social roles.11 It is a 10-
point visual analogue scale labelled none (0) to very severe 
(10). Respondents were also asked whether they had received 
treatment for emotional problems during the preceding 12 
months.   
Procedure
Interviewers were trained in the administration of the CIDI 
in centralised group sessions lasting 1 week. Two formal pre-
tests of all of the survey questions were completed, with a 
total of over 50 respondents participating. The interviews were 
conducted face-to face in seven different languages: English, 
Afrikaans, Zulu, Xhosa, Northern Sotho, Southern Sotho and 
Tswana. The protocol was reviewed by the ethics committee of 
the Medical University of South Africa, and all subjects gave 
informed consent. Interviews lasted an average of 3½ hours, 
with some requiring more than one visit to complete. Data 
were collected between January 2002 and June 2004.
Statistical analysis
All analyses reported accounted for the complex survey design 
based on person-level weights that incorporated sample 
selection, non-response and post-stratification factors. Data 
were analysed using Stata Version 10.0 (Stata Corporation, 
College Station, USA). 
Results
The total sample of 4 351 adults was largely female (53.7%) and 
black (76.2%), although other racial groups were represented 
(10.4% coloured, 10% white, 3.4% Indian/Asian). Further, half 
were married, while most were unemployed (69.2%), had less 
than 12 years of education (62.7%), and lived in urban areas 
(59.7%) (Table I). 
Prevalence of major depressive episode
The prevalence of major depressive episode (MDE) in the total 
sample was 9.7% for lifetime and 4.9% for the 12 months prior 
to the interview. The prevalence of MDE was significantly 
higher among female respondents, with females 1.75 times 
more likely to experience lifetime depression than males (95% 
confidence interval (CI) 1.3 - 2.4), and 2.17 times more likely to 
experience 12-month MDE than males (95% CI 1.5 - 3.2) (Table 
I). 
Socio-demographic correlates
The prevalence of MDE was significantly higher among those 
with a low average level of education, people with Grade 1 - 7 
schooling being 2.11 times more likely to have experienced 
lifetime MDE (95% CI 1.2 - 3.7) and 3.70 times more likely to 
have experienced 12-month MDE (95% CI 1.5 - 9.3) than those 
with higher levels of education (Table I). The prevalence of 
MDE was also significantly higher among people between the 
ages of 40 and 49 years, who were 1.71 times more likely to 
have experienced lifetime MDE (95% CI 1.3 - 2.3) than other 
age groups. No other socio-demographic correlates were 
related to either lifetime or 12-month MDE. 
Age of onset and mean number of MDEs
The mean age of onset of MDE was 25.8 years for the total 
sample, 26 years for females and 25.6 years for males. There 
were no significant differences for mean number of lifetime 
episodes across age cohorts or between genders. Kaplan-Meier 
curves for age at onset of depression were generated for four 
groups defined by age at interview (18 - 29 years, 30 - 39 years, 
40 - 49 years and >50 years). Risk is low until the early teens, 
and then begins to rise increasingly steeply in more recent 
cohorts (Fig. 1).
12-month treatment
In the past 12 months, 8.2% of people with lifetime major 
depressive disorder had spoken to a psychiatrist. People 
with major depression were 2.2 times more likely to report 
speaking to (or receiving treatment from) a psychiatrist in 
the past 12 months compared with those without lifetime 
major depression. Those with major depression were also 
over 2 times more likely to have spoken to another mental 
health professional, 1.47 times more likely to have spoken to 
a general practitioner, 2.03 times more likely to have spoken 
to a religious adviser, and over 2.5 times more likely to have 
spoken to a healer compared with those without lifetime major 
depression (Table II).
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Role impairment of 12-month MDE
Over 90% of respondents with a MDE reported global role 
impairment (using the Sheehan disability scale). Across all 
dimensions of the Sheehan scale the only significant gender 
difference was that women were more likely than men to 
report a home impairment (p=0.037) (Table III). Respondents 
with MDE reported a mean of 57 days out of role when, as 
a result of the depression, they were unable to perform their 
normal activities. Males over 50 years reported a markedly 
higher number of days out of role (128 days) than any other 
age cohort, while males in that age cohort reported almost 
three times the number of days out of role (128 days v. 66 days) 
than females of the same age. 
Discussion
The prevalence of MDE in South Africa was 9.8% for lifetime 
and 4.9% for the past 12 months. These rates were lower 
than those found in the in the National Comorbidity Survey 
Replication,12 where lifetime and 12-month prevalence rates 
were 16.2% and 6.6%, respectively. In the World Health 
Organization WMH survey prevalence rates for any mood 
disorder ranged from 3.3% in Nigeria to 21.4% in the USA, 
while projected lifetime risk for any mood disorder ranged 
from 7.3% in China to 31.4% in the USA.13 So while South 
African rates are lower than those in the USA they are 
considerably higher than an estimate in a recent survey of 
Yoruba-speaking Nigeria14 and higher than in the majority 
of other countries that have participated in the first wave of 
Table I. Description of sample, according to prevalence of major depression
             Lifetime DSM-IV major depression* 12-month DSM-IV major depression*
   Total population  % OR (95% CI)   % OR (95% CI)
N  (%)   4 351 (100%)  439 (9.7)          -    223 (4.9)             -
Demographic characteristics
Mean age (yrs) (SE) 37.0 (0.26)  37.8           -    37.9             -
Age categories (yrs)
   18 - 29  39.1   32.7          -    31.9             -
   30 - 39  22.1   23.4          -    23.8             -
   40 - 49  18.1   24.5          -    22.5             -
   ≥50   20.7   19.4          -    21.8             -
Gender 
   Male   46.3   33.9 1.0    28.8 1.0
   Female  53.7   66.1 1.75 (1.3 - 2.4)   71.2 2.17 (1.5 - 3.2)
Race
   Black   76.2   75.4 1.0    72.5 1.0
   Coloured  10.4   11.1 1.05 (0.8 - 1.5)   13.3 1.31 (0.9 - 2.0)
   White  10.0   8.9 0.84 (0.3 - 2.2)   7.0 0.69 (0.2 - 2.2)
   Indian/Asian  3.4   4.6 1.42 (0.7 - 3.0)   7.3 2.38 (1.0 - 5.7)
Currently married 50.1   48.3 0.78 (0.6 - 1.0)   52.5 0.95 (0.7 - 1.3)
Location
   Rural   38.4   35.1 1.0    35.1 1.0
   Urban  61.6   64.9 1.15 (0.9 - 1.5)   64.9 1.15 (0.8 - 1.6)
SES tertile
   0   30.4   31.4 1.0    31.9 1.0
   1   33.3   30.5 0.90 (0.7 - 1.2)   31.4 0.94 (0.6 - 1.4)
   2   36.3   38.1 1.03 (0.7 - 1.5)   36.7 0.99 (0.6 - 1.6)
Socio-economic status
   Education
   None   6.8   4.9 1.0    3.3 1.0
   Grade 1 - 7   19.1   27.6 2.11 (1.2 - 3.7)   32.6 3.70 (1.5 - 9.3)
   Grade 8 - 11  35.4   33.8 1.36 (0.8 - 2.2)   36.1 2.18 (1.0 - 5.0)
   Matric  23.5   21.5 1.38 (0.8 - 2.4)   13.9 1.28 (0.5 - 3.3)
   Matric+  15.3   12.3 1.12 (0.6 - 2.1)   14.1 1.94 (0.7 - 5.4)
Employed   31.0   32.0 0.95 (0.6 - 1.4)   30.6 0.89 (0.6 - 1.4)
Income categories (R),                   -                 -
personal (mean (SD))
   0   13.7   12.5 1.0    18.1 1.0
   1 - 2 500  29.5   35.6 1.31 (0.8 - 2.2)   28.6 0.69 (0.4 - 1.2)
   2 501 -  5 000  15.4   12.3 0.84 (0.5 - 1.4)   11.0 0.51 (0.3 - 1.0)
   5 001 - 10 000  19.6   18.5 0.99 (0.6 - 1.8)   17.0 0.62 (0.3 - 1.3)
   ≥10 001  21.8   21.1 1.03 (0.6 - 1.8)   25.3 0.85 (0.4 - 1.7)
*Odds ratios adjusted for age categories.
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the WHO WMH initiative.15 The Nigerian figures are likely 
to be underestimates, which is underscored by Gureje and 
colleagues’16 recent finding that among people over the age 
of 65 in Nigeria the lifetime prevalence of major depressive 
disorder was 26.2% while the 12-month prevalence was 7.1%. 
The high lifetime prevalence estimates for psychiatric 
disorders found here are broadly consistent with previous 
work in South Africa. A community prevalence study of 
psychiatric morbidity in a rural coloured village found a 
prevalence of psychiatric morbidity of 27.1%, with the majority 
of cases diagnosed with depressive or anxiety disorder.5 
Similarly, the rate of depression in a local primary care clinic 
was 37%.17 The association of mood disorder with gender 
(female gender associated with higher rates of MDE) is 
consistent with findings in rich and low- and middle-income 
countries. 
The mean age of onset (25.8 years for the total sample, 26 
years for females and 25.6 years for males) is in line with 
the median age-of-onset distributions in both the National 
Comorbidity Survey12 and the WMH survey13 and elsewhere, 
where age at onset is concentrated in the late 20s.18
The results regarding role impairment suggest that MDE 
is a seriously impairing condition, which is in line with other 
findings. In the South African context, the mean 57 days out of 
role is markedly higher than (for example) the 35.1 mean days 
out of role in the National Comorbidity Survey.12 These data, 
together with the fact that males over 50 years reported 128 
days out of role, has crucial implications for productivity in the 
workplace, considering that in a study of the effects of chronic 
medical conditions on work loss, the mean number of days out 
of role for most of the chronic conditions was less than 15.19 
Such data have been criticised by those who argue that 
distress in the developing world should not be conflated 
with the presence of psychiatric disorders, and who question 
the applicability of the DSM classification system to non-
Western countries.20 There is growing acceptance, however, 
that psychiatric disorders, as classified by the DSM-IV and 
diagnosed by instruments such as the CIDI, are accompanied 
by significant social and occupational impairment. This is 
Fig. 1. Cumulative lifetime prevalence of MDE by birth cohort.
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Fig. 1. Cumulative lifetime prevalence of MDE by birth cohort.
Table II. Service use in the past 12 months by lifetime major depression
            DSM-IV major          No  DSM-IV       
    Total population       depression          major depression            OR            p-value
Lifetime major depression
N (%)         4 351 (100)       439 (9.7)          3 912 (90.3)
Psychiatrist        4.3        8.2           3.9   2.20           0.001
Any other mental        3.5        6.4           3.2   2.07           0.011
health professional*
General practitioner†       13.3        17.9           12.9   1.47           0.049
Traditional healer       6.5        9.0           6.2   1.50           0.067
Any other health professional‡      7.6        8.5           7.5   1.15           0.491
Religious or spiritual advisor§      6.9        12.0           6.3   2.03            0.001
Any other healer¶       2.2        4.8           1.9   2.59            <0.001
12-month major depression
N (%)         4 351 (100%)       223 (4.9)          4 128 (95.2)
Psychiatrist        4.3        12.6           3.9   3.56           <0.001
Any other mental health professional*     3.5        10.5           3.2   3.59           <0.001
General practitioner†       13.3        20.7           13.0   1.76           0.014
Traditional healer       6.5        10.8           6.3   1.82           0.024
Any other health professional‡      7.6        7.1           7.6   0.93           0.819
Religious or spiritual advisor§      6.9        10.2           6.7   1.58           0.087
Any other healer ¶       2.2        6.9           2.0   3.65           <0.001
*Any other mental health professional, such as a psychologist, psychotherapist, psychiatric social worker, mental health nurse or mental health counsellor.  
†A general practitioner or any other medical doctor. 
‡Any other health professional, such as a nurse or physician’s assistant.
§A religious or spiritual advisor, such as a minister, priest or rabbi.
¶Any other healer, such as a chiropractor or spiritualist.
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certainly borne out by our findings. Furthermore, research on 
pathogenesis and intervention has demonstrated that such 
disorders are associated with psychobiological dysfunction 
and that efficacious and cost-effective treatments are available, 
even in a developing-world context.21,22 This is not to minimise 
the potentially important effects of cultural context on the 
experience and expression of psychiatric disorders. 
The paucity of data on mental disorders in low- and 
middle-income countries (LAMICs) significantly hampers 
the development of new and innovative interventions. The 
use of a standard instrument to detect depression renders us 
vulnerable to the criticism that we are potentially ignoring 
relevant culturally specific idioms of distress. Developing 
instruments that are culturally appropriate to the population 
being investigated is a useful approach, in that local idioms 
of distress are incorporated. One of the disadvantages of 
such instruments, however, is that they may limit between-
country comparisons, and thus the cost-effective adaptation 
of innovative interventions that have been developed 
elsewhere. Clearly, both quantitative and qualitative research 
skills (combining both epidemiological and anthropological 
approaches) are needed in order to develop a full 
understanding of the presentation and prevalence of affective 
disorders and models of the most appropriate care.
There are important limitations that should be noted, all 
of which are likely to make the lifetime prevalence estimates 
here conservative.23 People with psychiatric disorders have 
been shown in other countries to be less likely than others 
to participate in mental health surveys.24 Another important 
limitation of the survey is the lack of clinical validation of 
the CIDI in the South African study. While results were 
reassuring in CIDI clinical validation studies carried out in 
conjunction with the WMH surveys in the USA23 and Europe,25 
the cultural heterogeneity of the South African subjects might 
have impacted adversely on the diagnostic accuracy of the 
instrument.
Rigorous data on the proportion of the health budget spent 
on mental health services in the South African setting are 
not readily available, but there is consensus that a gross lack 
of parity exists, with significant under-funding of mental 
health services and research.26 In addition, there is a lack of 
research related to developing mental health interventions 
that can be scaled up and that do not need to be delivered by 
mental health professionals – a critical intervention in LAMIC 
countries, given the existing human resource crisis. We hope 
that the data reported here take a first step in documenting a 
level of need for care that is sufficiently compelling to provide 
impetus for changes in mental health policy in South Africa, 
Table III . Role impairment and depression, by sex
     Lifetime major depressive disorder  12-month major depressive disorder 
     Men      Women   Men      Women
     (%)      (%)           p-value  (%)      (%)            p-value
Mean days out of role in the past 12 months (N) 72.6      51.2    72.6      51.2
Home 
None     70.2      56.6            0.037  29.5      18.7             0.052
Mild     12.2      7.5    28.9      14.1 
Moderate    10.8      15.8    25.5      29.6 
Severe     3.6      11.8    8.6      22.1 
Very severe    3.2      8.3    7.5      15.5 
Work 
None     72.8      59.4            0.161  35.5      23.9             0.278
Mild     8.7      7.2    20.6      13.5 
Moderate    9.5      16.5    22.4      30.9 
Severe     4.6      12.6    11.0      23.5 
Very severe    44.8      4.4    10.6      8.2 
Relationships
None     72.2      58.5            0.180  34.3      22.2             0.311
Mild     2.0      10.5    16.6      19.7 
Moderate    7.2      14.9    17.1      27.9 
Severe     8.2      12.6    19.3      23.6 
Very severe    5.4      3.6    12.7      6.7 
Social
None     71.8      59.5            0.173  33.3      24.1             0.293
Mild     6.1      11.9    14.4      22.4 
Moderate    11.5      11.6    27.1      21.7 
Severe     3.9      11.0    9.2      20.5 
Very severe    6.8      6.1    16.0      11.4 
Any impairment    88.3      94.5            n/a  88.3      94.5             n/a
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with an appropriate increase in funding for mental health 
services. 
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